ACE Agenda
Attendees experienced 2-days of exclusive sessions on injectables, devices, skin, medical longevity, business, and beyond from world-renowned KOLs. Take a look at our ACE speakers by simply clicking the ‘speakers’ icon below.
Discover our conference programme and stages, a two day extravaganza of free educational content…
Discover our conference programme and stages, a two day extravaganza of free educational content…
Attendees experienced 2-days of exclusive sessions on injectables, devices, skin, medical longevity, business, and beyond from world-renowned KOLs. Take a look at our ACE speakers by simply clicking the ‘speakers’ icon below.
Across the two days at ACE some sessions may only be open to practitioners on specific medical registers – GMC, NMC, GDC, GPhC, HCP – and the prescribing qualification.
At ACE, these requirements are put into place by the sponsors hosting the session. Any further questions you may have should be directly addressed to the session host. The sessions which have been sponsored will have the brand name in the title. All content shown in the Teoxane Main Auditorium and the Symposium Stage will have restrictions and some sessions in the Masterclass Agenda. In Practice Theatre and Innovation Stage sessions are open to all.
If you believe you should be given access to these sessions, please email contact@aestheticsjournal.com or visit a registration desk on site. Full details will be displayed on the website agenda and on the ACE app.
AbbVie has part sponsored this event, this includes provision of a stand and a speaker program. AbbVie has had no influence over the content/topics covered in other parts of the agenda.
Friday 14 March 2025
09:00 – 17:30
Saturday 15 March 2025
09:00 – 16:00
Business Design Centre
52 Upper St, The Angel, London N1 0QH
You must be 18+ to attend
*AbbVie has part sponsored this event, this includes provision of a stand and/or a speaker program/medical symposium. AbbVie has had no influence over the content / topics covered in other parts of the agenda.